GWPH - GW Pharmaceuticals plc

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

Currency in GBP. All numbers in thousands
Total Revenue11,05313,39943,231
Cost of Revenue4,7513,5323,966
Gross Profit6,3029,86739,266
Operating Expenses
Research Development149,231129,660116,311
Selling General and Administrative55,94625,90119,039
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-205,643-112,503-86,690
Income from Continuing Operations
Total Other Income/Expenses Net-4,60133,9819,765
Earnings Before Interest and Taxes-203,474-111,713-86,320
Interest Expense1,000225114
Income Before Tax-204,474-111,938-86,434
Income Tax Expense-27,795-29,247-18,931
Minority Interest---
Net Income From Continuing Ops-176,679-82,691-67,502
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-176,679-82,691-67,502
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-176,679-82,691-67,502